volume 10 issue 6 pages 2093-2110

Nanoparticle characterization: state of the art, challenges, and emerging technologies.

Publication typeJournal Article
Publication date2013-03-21
scimago Q1
wos Q1
SJR0.968
CiteScore7.8
Impact factor4.5
ISSN15438384, 15438392
PubMed ID:  23461379
Drug Discovery
Pharmaceutical Science
Molecular Medicine
Abstract
Nanoparticles have received enormous attention as a promising tool to enhance target-specific drug delivery and diagnosis. Various in vitro and in vivo techniques are used to characterize a new system and predict its clinical efficacy. These techniques enable efficient comparison across nanoparticles and facilitate a product optimization process. On the other hand, we recognize their limitations as a prediction tool, due to inadequate applications and overly simplified test conditions. We provide a critical review of in vitro and in vivo techniques currently used for evaluation of nanoparticles and introduce emerging techniques and models that may be used complementarily.
Found 
Found 

Top-30

Journals

1
2
3
4
5
6
7
RSC Advances
7 publications, 2.26%
Analytical Chemistry
6 publications, 1.94%
Journal of Controlled Release
5 publications, 1.61%
International Journal of Pharmaceutics
5 publications, 1.61%
Molecular Pharmaceutics
5 publications, 1.61%
Pharmaceutics
4 publications, 1.29%
International Journal of Molecular Sciences
4 publications, 1.29%
Advanced Drug Delivery Reviews
4 publications, 1.29%
Langmuir
4 publications, 1.29%
ACS Applied Bio Materials
4 publications, 1.29%
Nanoscale
3 publications, 0.97%
Journal of Nanoparticle Research
3 publications, 0.97%
Colloids and Surfaces A: Physicochemical and Engineering Aspects
3 publications, 0.97%
Journal of Physical Chemistry C
3 publications, 0.97%
Nanomedicine
2 publications, 0.65%
ACS Applied Nano Materials
2 publications, 0.65%
Nanomaterials
2 publications, 0.65%
Crystals
2 publications, 0.65%
Bulletin of Engineering Geology and the Environment
2 publications, 0.65%
Analytical and Bioanalytical Chemistry
2 publications, 0.65%
Pharmaceutical Research
2 publications, 0.65%
Scientific Reports
2 publications, 0.65%
Nature Communications
2 publications, 0.65%
Journal of Molecular Liquids
2 publications, 0.65%
Spectrochimica Acta, Part B: Atomic Spectroscopy
2 publications, 0.65%
New Biotechnology
2 publications, 0.65%
Journal of Drug Delivery Science and Technology
2 publications, 0.65%
Nanomedicine: Nanotechnology, Biology, and Medicine
2 publications, 0.65%
Drug Discovery Today
2 publications, 0.65%
1
2
3
4
5
6
7

Publishers

10
20
30
40
50
60
70
80
90
Elsevier
85 publications, 27.42%
Springer Nature
47 publications, 15.16%
American Chemical Society (ACS)
35 publications, 11.29%
Wiley
25 publications, 8.06%
Royal Society of Chemistry (RSC)
24 publications, 7.74%
MDPI
23 publications, 7.42%
Taylor & Francis
16 publications, 5.16%
Bentham Science Publishers Ltd.
6 publications, 1.94%
Frontiers Media S.A.
4 publications, 1.29%
Hindawi Limited
4 publications, 1.29%
Walter de Gruyter
4 publications, 1.29%
IOP Publishing
3 publications, 0.97%
A and V Publications
2 publications, 0.65%
Pharmaceutical Society of Korea
1 publication, 0.32%
Scientific Publishers
1 publication, 0.32%
Maad Rayan Publishing Company
1 publication, 0.32%
American Society for Biochemistry and Molecular Biology
1 publication, 0.32%
Korean Vaccine Society
1 publication, 0.32%
American Institute of Mathematical Sciences (AIMS)
1 publication, 0.32%
Zhejiang University Press
1 publication, 0.32%
Oxford University Press
1 publication, 0.32%
Optica Publishing Group
1 publication, 0.32%
Innovare Academic Sciences
1 publication, 0.32%
University of Huddersfield Press
1 publication, 0.32%
Edizioni Minerva Medica
1 publication, 0.32%
IGI Global
1 publication, 0.32%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.32%
Cold Spring Harbor Laboratory
1 publication, 0.32%
AIP Publishing
1 publication, 0.32%
10
20
30
40
50
60
70
80
90
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
310
Share
Cite this
GOST |
Cite this
GOST Copy
Cho E. et al. Nanoparticle characterization: state of the art, challenges, and emerging technologies. // Molecular Pharmaceutics. 2013. Vol. 10. No. 6. pp. 2093-2110.
GOST all authors (up to 50) Copy
Cho E., Holback H., Liu K. C., Abouelmagd S. A., Park J. Y., Yeo Y. Nanoparticle characterization: state of the art, challenges, and emerging technologies. // Molecular Pharmaceutics. 2013. Vol. 10. No. 6. pp. 2093-2110.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/mp300697h
UR - https://doi.org/10.1021/mp300697h
TI - Nanoparticle characterization: state of the art, challenges, and emerging technologies.
T2 - Molecular Pharmaceutics
AU - Cho, Eun Jung
AU - Holback, Hillary
AU - Liu, Karen C
AU - Abouelmagd, Sara A.
AU - Park, Joon Young
AU - Yeo, Yoon
PY - 2013
DA - 2013/03/21
PB - American Chemical Society (ACS)
SP - 2093-2110
IS - 6
VL - 10
PMID - 23461379
SN - 1543-8384
SN - 1543-8392
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2013_Cho,
author = {Eun Jung Cho and Hillary Holback and Karen C Liu and Sara A. Abouelmagd and Joon Young Park and Yoon Yeo},
title = {Nanoparticle characterization: state of the art, challenges, and emerging technologies.},
journal = {Molecular Pharmaceutics},
year = {2013},
volume = {10},
publisher = {American Chemical Society (ACS)},
month = {mar},
url = {https://doi.org/10.1021/mp300697h},
number = {6},
pages = {2093--2110},
doi = {10.1021/mp300697h}
}
MLA
Cite this
MLA Copy
Cho, Eun Jung, et al. “Nanoparticle characterization: state of the art, challenges, and emerging technologies..” Molecular Pharmaceutics, vol. 10, no. 6, Mar. 2013, pp. 2093-2110. https://doi.org/10.1021/mp300697h.